Ghent - February 12, 2008 – 8.00 AM (CET) – Last year, Innogenetics decided to focus on the development and sales of diagnostic products, and GENimmune N.V. was incorporated as a fully owned ...

"We believe our proposed acquisition of Innogenetics would provide strategically valuable marketing and sales, distribution and manufacturing capabilities to accelerate commercialization of Gen-Probe ...

Solvay has made a $278.2 million (€177.6 million) takeover bid for Belgium's Innogenetics. The companies have been R&D partners since 1997, and Solvay is the company's second largest shareholder, with ...

BRUSSELS, July 9 (Reuters) - Belgian drugmaker Solvay increased its bid for biotech company Innogenetics on Wednesday, beating off a rival offer from U.S. disease diagnosis firm Gen-Probe Inc . Sign ...

Solvay Pharmaceuticals has tabled a bid of 177.6 million euros to acquire fellow Belgian firm Innogenetics in a bid to expand its personalised medicines operations. Solvay Pharmaceuticals has tabled a ...

SAN DIEGO, July 9 Gen-Probe Incorporated(Nasdaq: GPRO) announced today that the Company does not intend to increasethe value of its conditional tender offer to acquire 100% of the outstandingshares, ...

Gen-Probe, which a month ago launched a risky takeover bid for the Belgian diagnostics maker Innogenetics, did indeed spark a counteroffer from Dutch drugmaker Solvay Pharmaceuticals and now appears ...

BRUSSELS, July 24 (Reuters) - Belgian drugs maker Solvay said on Thursday it planned to open its 6.50 euros per share offer for Innogenetics from August 12 to September 5. Solvay increased its bid for ...

Solvay will acquire Innogenetics for about $280 million, a 53% premium to the diagnostics company's stock market value before the deal was announced. Solvay already owns a 7% stake in Innogenetics, ...

Third Wave Technologies Inc. and Innogenetics have jointly announced that the companies have reached an agreement by which Third Wave Technologies will receive a non-exclusive license to sell ...

Innogenetics said the damage award may be increased up to three times at the judge's discretion and that it would seek an injunction against Abbott's diagnostic products that infringe its patent.

LONDON (MarketWatch) -- Biopharmaceutical Innogenetics said Thursday that the U.S. District Court for the Western District of Wisconsin has entered a permanent injunction against Abbott Laboratories .